Document:

Exhibit 10.17
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder identified by the mark “[***]”.
June 11, 2016
Mr. Michael Voslow 
[***]
Subject: Employment Offer
Dear Michael:
Brivo Inc (the “Company” or “Brivo”) is pleased to offer you employment according to the conditions outlined herein and as described in the enclosed “Employment Conditions” and “Employee Confidential Information, Inventions, and Non-Competition Agreement”.  A description of the responsibilities and goals of this position are also enclosed and are subject to change as the Company may require.  This offer is as follows:
	1.
	Effective Date of Employment: Your new employment conditions would begin at the date described in the “Employment Conditions” below.  Your salary will be paid by bank transfer (direct deposit) twice per month, on the 15th and 30th of every month, representing the work periods of the 1st to the 15th and of the 16th to the last day of the month, respectively.

	2.
	At-Will Employment: Your employment is “at-will.”  You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying your manager in writing.  Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice.  This at-will employment relationship cannot be changed except in writing by your manager.

	3.
	Fringe Benefits: You will be eligible to participate in any Company benefit program as described in the “Employment Conditions” below and in the Company’s Employee Manual & Handbook (“Employee Manual”) on the same basis as other employees of the Company, who are at a comparable level, including the Company’s health insurance program.  The Company may modify all benefits described herein from time to time.

	4.
	Code of Conduct: As an employee of Brivo Inc, you will be required to abide by Company rules and regulations.  Your offer of employment is conditioned upon your execution of the attached Proprietary Information, Inventions, and Non-Competition Agreement.  Depending upon the needs of the Company, you may be asked to work hours that differ from the Company standard.  As an exempt salaried employee, you may be expected to work additional hours as required by the nature of your work assignments.  In your work for the Company, you will be expected not to use or disclose any confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of confidentiality.

​

​
​
	Employment Offer Letter
	Page 1 of 10

​

Rather, you will be expected to use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation of confidentiality.
	5.
	Entire Agreement/Governing Law: This Agreement and the attached Proprietary Information, Inventions, Non-Competition Agreement, and if applicable, Relocation Agreement are the entire agreement between you and Brivo Inc and supersede and govern over any other agreements or promises made to you by anyone, whether oral or written. This Agreement can be modified only by a written agreement signed by an authorized representative of Brivo Inc. As required by law and indicated below, this offer is subject to satisfactory proof of your right to work in the United States.

	6.
	Severance: Employee shall be paid at termination, three (3) months base salary in the event that: a) employee is terminated without cause, b) company undergoes a significant change, such that employee’s original role, responsibilities, and incentive compensation goals can no longer reasonably be achieved (such change in control or ownership resulting in such) Severance payment will be subject to execution of a standard severance agreement, return of company property, etc.

This Agreement shall be executed, construed and performed in accordance with the laws of the State of Maryland without reference to conflict of laws principles. The parties agree that the venue for any dispute hereunder will be the state or federal courts sitting in Montgomery County, Maryland and the parties hereby agree to the exclusive jurisdiction thereof.
This letter supersedes any previously made offer, verbal or written, for employment by the Company. Please sign and date one copy of this letter, and return it to me by email, fax, first class mail or in person before close of business on the expiration date specified below if you wish to accept employment at Brivo Inc under the terms described above. If you accept our offer, we would like you to start as soon as is practical.
This offer and, subsequently, your employment are subject to the following conditions:
		●	The information provided to the Company to evaluate your application was complete and true;

​
		●	You agree to and successfully pass a background check;

​
		●	You must supply your services to the Company in a conscientious manner, with all of your abilities, and always in the Company’s best interests, in accordance with its procedures, policies or habits and these services will be made available to the Company on an exclusive basis during your employment;

​
		●	You will sign and maintain a Non-Disclosure Agreement and a Non-Competition Agreement;

​

​
​
	Employment Offer Letter
	Page 2 of 10

​

If you agree to these conditions, please sign a copy of this letter and a copy of the “Employment Conditions” form and return to the undersigned.
We are delighted to retain you as part of our team and we believe that your skills will enable you to contribute to Brivo’s success and future development.
	​

	​

	Sincerely,
	​

	​
	​

	/s/ Steve Van Till
	​

	Steve Van Till
President & CEO
	​

​
​

​
​
	Employment Offer Letter
	Page 3 of 10

​

I accept this Employment Offer, as per the “Employment Conditions” and “Employee Confidential Information, Inventions, and Non-Competition Agreement”, and I have received a copy of these documents.
​
	Printed Name:
	Michael Voslow

	​
	​

	Signature:
	/s/ Michael Voslow

	​
	​

	Date:
	June 14, 2016

​
​

​
​
	Employment Offer Letter
	Page 4 of 10

​

EMPLOYMENT OFFER
	Employee:
	Michael Voslow

	​
	​

	Position/Title:
	Chief Financial Officer

	​
	​

	Start Date:
	To be agreed.

	​
	​

	Annual Salary:
	$250,000

	​
	​

	Stock Options:
	150,000 stock options, as defined in Brivo’s Employee Stock Option Program.

	​
	​

	Next Review Date:
	January 2017

	​
	​

	Work Hours:
	At least 40 hours per week, within 7 AM and 6 PM. However, all employees must be present during the core hours of 9 AM to 5 PM unless supervisor approves alternative schedule. Lunch periods are not paid.

	​
	​

	Location:
	At Brivo Inc headquarters, located at 7700 Old Georgetown Road, Bethesda, MD 20814

	​
	​

	Offer expiration:
	June 20, 2016

​
Benefits and Other Conditions:
		●	Group Health Insurance, including a 401(k) plan;

		●	Discretionary Time Off

		●	Gym reimbursement

	​

	​

	​

	​

	​

	Approved by:
	 ​
	Candice Scott
	 ​
	Date: 
	June 11, 2016
	​

	​
	​
	​
	​
	​

	Read and accepted:
	​
	/s/ Michael Voslow
	​
	Date: 
	June 14, 2016
	​

	​
	​
	(Employee’s signature)
	​
	​

​
​

​
​
	Employment Offer Letter
	Page 5 of 10

​

EMPLOYEE CONFIDENTIAL INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT
In consideration of my employment, and access to confidential information, the undersigned employee of Brivo Inc. (hereinafter “the Company”) hereby agrees and covenants as follows:
PART 1 - CONFIDENTIALITY AND NON-DISCLOSURE
As an employee of the Company, I will be exposed to highly sensitive and confidential information (some of which I may develop or contribute to) not generally, if at all, known or available to persons or entities not in some way affiliated with the Company (hereafter “proprietary information”). Among such matters, I may be involved with or become aware of: research and development projects; the identity of consultants and assistants; future advertising and marketing methods, campaigns and strategies; sales and pricing information and formulas; budgets; product performance; sources of products; production and distribution methods or procedures; product availability; customer product preferences and requirements; customer purchases, orders, leads and quotations; and, additional information relating to financial, marketing, technical, developmental and/or other business aspects, of the Company and/or its affiliates. I agree and understand that any and all of the foregoing is considered by the Company to be of a highly confidential nature and as a trade secret. In furtherance of the foregoing, I agree as follows:
1.To refrain from reproducing or making any summary, extract or abridgement of, other than in the regular course of business, or removing, any business record, document, schematic, drawing instrument, component or any other item dealing with the proprietary information without prior written consent therefor. Notwithstanding the foregoing, where I am required to take confidential information into the field to perform my duties, or where I have permission from my supervisor to take work home at night, I shall take all reasonable steps to protect the confidentiality of such information.
2.To refrain from discussing with any other person or persons, whether or not such persons are in the employ of the Company, any aspect of the proprietary information, except as such discussions directly relate to completion of the particular task at hand and/or in compliance with instructions to do so.
3.To accept and maintain the proprietary information on a confidential basis and to protect and effectively safeguard same against unauthorized publication or disclosure. I will not be justified in disregarding the obligation of confidentiality by selecting individual pieces of public information and fitting them together by use of integrated disclosure to contend that such proprietary information is in the public domain.
4.Other than in furtherance of the Company’s business, not to use, directly or indirectly, for my own or for my future employer’s advantage, any proprietary information learned during my employment with the Company and which is not made publicly known (through no fault of mine).
​

​
​
	Employment Offer Letter
	Page 6 of 10

​

5.Not to disclose, publicize, reveal or make available, directly or indirectly, any of the proprietary information to any firm, person, or entity whatsoever, except for a disclosure which is required, if at all, by statute, order of court or otherwise by law, and then only after first advising the Company of such demand with reasonably sufficient advance notice so as to afford the Company an opportunity to seek a protective order.
6.Upon termination of my employment, to turn over to a designated individual employed by the Company all property then in my possession or control belonging to the Company. I will not retain any original, copy, summary, extract or abridgement of any document which contains proprietary information, whether in written, graphic, tangible, electronic or magnetic format, including correspondence, memoranda, reports, notebooks, drawings, photos, information stored in computer memory or on disk or other documents relating in any way to the affairs of the Company or to the affairs of its affiliated companies, howsoever coming into my possession or control or developed by me at any time during my employment with the Company, all of which will be delivered to the Company immediately upon termination of my employment.
7.Not to interfere with the relationship between and/or among the Company and its consultants, agents, employees, sales representatives or others providing services or products to or for the Company, nor to disclose the identity of said individuals and/or entities so long as not otherwise generally known in the trade.
I represent and warrant that I do not have any confidential information of any third party, the disclosure of which will be unlawful or in violation of any agreement I may have with any third party, not obtained in the course of my employment with the Company; or, alternatively, that I have disclosed to the Company, in writing, the existence (but not the confidential information itself) of such information and agreements.
I represent and warrant that by virtue of the terms of my employment with the Company, I am not currently, and will not be, in breach of any agreement (including any agreement with any prior employer) that I may be party to.
I undertake to comply with all physical security procedures of the Company and to take all computer system security measures as requested by the Company, and to maintain the Company’s proprietary notices on any material that emanates from me during the course of my employment.
I acknowledge and agree that the propriety information, and the strict confidentiality thereof, materially affects the successful conduct of the Company’s current and future business and its goodwill; therefore, any breach of the terms of this Agreement by me is a material breach thereof, and may result in immediate termination of my employment, the imposition of injunctive relief and liability for damages sustained by the Company.
The covenants and agreements undertaken herein shall survive termination of my employment, and shall be binding upon me.
​

​
​
	Employment Offer Letter
	Page 7 of 10

​

PART 2 - EMPLOYEE IMPROVEMENTS
I further agree that I will promptly, fully inform and disclose to the Company all inventions, copyrights, processes, designs, improvements and discoveries (the foregoing shall include, but not be limited to, patentable teachings, patents, trademarks, trade-names, service marks, service names, copyrights, copyrightable matters, applications for the foregoing, trade­secrets and know-how) which I now have or may hereafter have, which result from any work performed by me for the Company. All such inventions, copyrights, designs, improvements and discoveries shall be the exclusive property of the Company. I hereby assign and agree to assign to the Company any and all right, title and interest in and to such inventions, copyrights, designs, improvements and discoveries and, upon request of the Company, I shall assist the Company to obtain patents from all such inventions, designs, improvements and discoveries deemed patentable by the Company and shall execute all documents and do all things necessary to obtain letters patents (Canada, U.S. and/or foreign countries), vest the Company with full and exclusive title thereto, and protect the same against infringement by others, including the making of all necessary truthful oaths and declarations, and any and all lawful documents deemed advisable for the preparation, filing prosecution, issuance, procurement and maintenance of patent applications and patents and for the transfer of interests including rights of priority. I hereby waive all moral rights I may acquire in all inventions, copyrights, processes, designs, improvements and discoveries.
The agreements in this Part 2 undertaken hereby shall survive termination of my employment.
PART 3 - NON-COMPETITION
During, and for a period of one year after termination of the Employee’s employment with the Company, unless otherwise agreed to by the Company, the Employee shall not, directly or indirectly, either as employee, employer, consultant, agent, principal, partner, co-venturer, shareholder (other than as a shareholder holding less than 5% in any publicly traded company), officer or director, or in any other individual or representative capacity:
(a)Engage or participate, anywhere in the world, in a business that will be in actual or potential competition in any manner whatsoever with the Company’s products or technology, whether existing at the date of this Agreement, or created during the course of the Employee’s employment; or
(b)Solicit customers that the Employee knows are customers of the Company; or
(c)Solicit other employees of the Company to leave the employment of the Company. Employee acknowledges and agrees that the covenants set forth above are appropriate and reasonable, are not oppressive to Employee and contain reasonable limitations as to time, scope, geographical area and activities and that Employee has received substantial consideration for agreeing to these covenants. The parties intend that the covenants contained in Part 3 shall be construed as a series of separate covenants, one for each country in the world, and for each province of Canada and each state of the United States. Except for geographical coverage, each such separate covenant shall be deemed identical in terms. Employee recognizes
​

​
​
	Employment Offer Letter
	Page 8 of 10

​

that the territorial restrictions contained in this Part 3 are reasonably required for the protection of the Company.
If in any judicial proceeding, a Court shall refuse to enforce any of the separate covenants (or any part thereof) deemed included, then such unenforceable covenant (or such part) shall be deemed eliminated from this Agreement for the purpose of those proceedings to the extent necessary to permit the remaining separate covenants (or portions thereof) to be enforced. In the event that the provisions of this Part 3 should ever be deemed to exceed the time or geographic limitations permitted by applicable law, then such provisions shall be reformed to the maximum time or geographic limitations, as the case may be, permitted by applicable laws.
​
​

​
​
	Employment Offer Letter
	Page 9 of 10

​

I have read and fully understand the foregoing contained in Parts 1, 2, and 3 above, and by affixing my signature below, I agree to be fully bound hereby.
I ATTEST TO HAVING SIGNED AT ___________________________________, THIS
14TH DAY OF THE MONTH OF JUNE 2016.
	​
	 ​
	Michael Voslow

	​
	​
	Employee’s Name (Please Print)

	​
	​
	​

	​
	​
	/s/ Michael Voslow

	Witness
	​
	Employee’s Signature

​
I confirm that I have received a copy of this agreement.
​
	​

	​

	​

	​

	Signature:
	/s/ Michael Voslow
	 ​
	Date: 
	June 14, 2016
	​

	Employee
	​
	​

​

​
​
	Employment Offer Letter
	Page 10 of 10

​EX-4.4

 Exhibit 4.4 

DESCRIPTION OF SECURITIES REGISTERED 

PURSUANT TO SECTION 12 OF THE 

SECURITIES EXCHANGE ACT OF 1934, AS AMENDED 

The following description of the capital stock of Everest Consolidator Acquisition Corporation (the “Company,” “we,” “us” and
“our”) summarizes certain provisions of our amended and restated certificate of incorporation. The description is intended as a summary, and is qualified in its entirety by reference to our amended and restated certificate of
incorporation, a copy of which has been filed as an exhibit to this Annual Report on Form 10-K. We are a Delaware corporation and our affairs are governed by our amended and restated certificate of
incorporation and the Delaware General Corporation Law (“DGCL”). The following also summarizes certain provisions of the DGCL and is subject to and qualified in its entirely by reference to the DGCL. Defined terms used herein, but
otherwise not defined, shall have the meaning ascribed to them in this Annual Report on Form 10-K. 
 General

 We have three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Act”): Units,
consisting of one share of our Class A common stock and one-half of one redeemable warrant, Class A common stock, par value $0.0001 per share, and warrants, exercisable for one share of Class A
common stock for $11.50 per share. The following summary includes a brief description of such securities as well as a description of our Class B common stock, par value $0.0001 per share (the “Class B common stock” or
“founder shares”), which is not registered pursuant to Section 12 of the Exchange Act but is convertible into shares of Class A common stock. The description of the Class B common stock is necessary to understand the
material terms of the Class A common stock. 
 Authorized Capital Stock 

Pursuant to our amended and restated certificate of incorporation our authorized capital stock consists of: 110,000,000 shares of common stock, $0.0001 par
value each, including 100,000,000 shares of Class A common stock and 10,000,000 shares of Class B common stock, as well as 1,000,000 shares of preferred stock, $0.0001 par value each. The following description summarizes certain terms of
our capital stock as set out more particularly in our amended and restated certificate of incorporation. Because it is only a summary, it may not contain all the information that is important to you. 

Units 
 Each unit consists of one share of Class A
common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.
Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the shares of our Class A common stock. This means only a whole warrant may be exercised at any given time by a warrant holder. 

The Class A common stock and warrants comprising the units began separately trading on January 14, 2022. Upon the commencement of separate trading,
holders have the option to continue to hold units or separate their units into the component securities. Holders need to have their brokers contact our transfer agent in order to separate the units into Class A common stock and warrants. No
fractional warrants will be issued upon separation of the units, and accordingly, we will round down to the nearest whole number the number of warrants to be issued to holders. Only whole warrants will trade. If, upon separation of the units, a
holder of warrants would be entitled to receive a fractional warrant, we will round down to the nearest whole number the number of warrants to be issued to such holder. Accordingly, unless you purchase at least two units, you will not be able to
receive or trade a whole warrant. 
 Additionally, the units will automatically separate, if not previously separated, into their component parts and will
not be traded after completion of our initial business combination. 

 Common Stock 

Holders of record of our Class A common stock are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of
shares of Class A common stock and holders of shares of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law. Unless specified in our amended and
restated certificate of incorporation, or as required by applicable provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted is required to approve any such matter
voted on by our stockholders. Our board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being elected in each year. There is no cumulative voting with respect
to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. Our stockholders are entitled to receive ratable dividends when, as and if declared by
the board of directors out of funds legally available therefor. Prior to our initial business combination, only holders of our founder shares will have the right to vote on the appointment of directors. Holders of our public shares will not be
entitled to vote on the appointment of directors during such time. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason.
These provisions of our amended and restated certificate of incorporation may be amended only by approval of at least 90% of the shares of our Class B common stock voting in an annual meeting. 

Because our amended and restated certificate of incorporation authorizes the issuance of up to 100,000,000 shares of Class A common stock, if we were to
enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number of shares of Class A common stock which we will be authorized to issue at the same time as our stockholders
vote on the business combination to the extent we seek stockholder approval in connection with our initial business combination. 
 Our board of directors
is divided into three classes with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term. In accordance with the NYSE
corporate governance requirements, we are not required to hold an annual meeting until one year after our first fiscal year end following our listing on the NYSE. Under Section 211(b) of the DGCL, we are, however, required to hold an annual
meeting of stockholders for the purposes of electing directors in accordance with our bylaws unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new directors prior to
the consummation of our initial business combination, and thus we may not be in compliance with Section 211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to the
consummation of our initial business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery in accordance with Section 211(c) of the DGCL. 

We will provide our public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business
combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business
combination, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes divided by the number of the then-outstanding public shares, subject to the limitations described herein. The amount in
the trust account was initially $10.20 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriter. The
redemption rights will include the requirement that a beneficial owner must identify itself in order to validly redeem its shares. Our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have
agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination, and (ii) a stockholder vote to approve an amendment to our
amended and restated certificate of incorporation (A) that would modify the substance or timing of our obligation to provide holders of shares of our Class A common stock the right to have their shares redeemed in connection with our
initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 15 months from the closing of our initial public offering (or 18 months or 21 months, as applicable) or (B) with
respect to any other provision relating to the rights of holders of shares of our Class A common stock. Unlike many blank check companies that hold stockholder votes and conduct proxy solicitations in conjunction with their initial business
combinations and provide for related redemptions of public shares for cash upon completion of such initial business 

 
combinations even when a vote is not required by law, if a stockholder vote is not required by applicable law or stock exchange listing requirements and we do not decide to hold a stockholder
vote for business or other reasons, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing
our initial business combination. Our amended and restated certificate of incorporation requires these tender offer documents to contain substantially the same financial and other information about the initial business combination and the redemption
rights as is required under the SEC’s proxy rules. If, however, a stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or we decide to obtain stockholder approval for business or other
reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek stockholder approval, we will complete our initial
business combination only if a majority of the shares of common stock voted are voted in favor of our initial business combination. However, the participation of our sponsor, officers, directors, advisors or their affiliates in privately-negotiated
transactions, if any, could result in the approval of our initial business combination even if a majority of our public stockholders vote, or indicate their intention to vote, against such initial business combination. For purposes of seeking
approval of the majority of our issued and outstanding shares of common stock, non-votes will have no effect on the approval of our initial business combination once a quorum is obtained. 

If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination
pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a
“group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to Excess Shares, without our prior consent. However, we would not be restricting our stockholders’ ability to
vote all of their shares (including Excess Shares) for or against our initial business combination. Our stockholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete our initial business
combination, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such stockholders will not receive redemption distributions with respect to the Excess Shares if we
complete our initial business combination. And, as a result, such stockholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their shares in open market transactions,
potentially at a loss. 
 If we seek stockholder approval in connection with our initial business combination, our sponsor and each member of our management
team have agreed to vote their founder shares and public shares in favor of our initial business combination. As a result, in addition to our sponsor’s founder shares, we would need 6,468,501 or 37.5% of the 17,250,000 public shares sold in our
initial public offering to be voted in favor of an initial business combination in order to have our initial business combination approved. Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they
vote for or against the proposed transaction or vote at all. 
 Pursuant to our amended and restated certificate of incorporation, we will have until 15
months from the closing of our initial public offering to consummate an initial business combination. However, if we anticipate that we may not be able to consummate our initial business combination within 15 months, we may, but are not obligated
to, extend the period of time to consummate a business combination by two additional three-month periods (for a total of up to 21 months from the closing of our initial public offering to complete a business combination). Our stockholders will not
be entitled to vote on, or redeem their shares in connection with, any such extension. This feature is different from some other special purpose acquisition companies, in which any extension of the company’s period to consummate an initial
business combination would require a vote of the company’s stockholders and in connection with such vote stockholders would have the right to redeem their public shares. Pursuant to the terms of our amended and restated certificate of
incorporation and the trust agreement to be entered into between us and American Stock Transfer & Trust Company, LLC, in order to extend the time available for us to consummate our initial business combination, our sponsor or its affiliates
or designees, upon five business days’ advance notice prior to each deadline, must deposit into the trust account an additional $0.10 per share of Class A common stock on or prior to the date of such deadline. At such additional deposits,
in each case, our sponsor or its affiliates or designees will receive an additional 1,150,000 private placement warrants , with the same terms as the original private placement warrants. In the event that we receive notice from our sponsor five
business days prior to a deadline of its intent to effect an extension, we intend to issue a press release announcing such intention at least three days prior to such deadline. In addition, we intend to issue a press release the day after a deadline
announcing whether or not the funds had been timely deposited. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination. 

 Pursuant to our amended and restated certificate of incorporation, if we have not consummated an initial
business combination within 15 months from the closing of our initial public offering (or 18 months or 21 months, as applicable), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously released to us to pay our taxes divided by the number of the then-outstanding public shares, which redemption will completely extinguish public stockholders’ rights as
stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors,
liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Our sponsor and each member of our management team have entered into an agreement
with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination within 15 months from the
closing of our initial public offering (or 18 months or 21 months, as applicable) or any other approved extension of such period (although they will be entitled to liquidating distributions from the trust account with respect to any public shares
they hold if we fail to complete our initial business combination within the prescribed time frame). 
 In the event of a liquidation, dissolution or
winding up of the company after a business combination, our stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if
any, having preference over the common stock. Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock, except that we will provide our public stockholders with the
opportunity to redeem their public shares for cash at a per share price equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our
taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding public shares, upon the completion of our initial business combination, subject to the limitations described herein. 

Founder Shares 
 The founder shares are designated as
Class B common stock and, except as described below, are identical to the shares of Class A common stock included in the units, and holders of founder shares have the same stockholder rights as public stockholders, except that:
(a) the founder shares are subject to certain transfer restrictions, as described in more detail below; (b) our sponsor and each member of our management team and board of directors have entered into an agreement with us, pursuant to which
they have agreed to (i) waive their redemption rights with respect to their founder shares and any public shares held by them in connection with the completion of our initial business combination; (ii) to waive their redemption rights with
respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to our amended and restated certificate of incorporation (A) that would modify the substance or timing of our obligation to provide
holders of shares of our Class A common stock the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 15
months from the closing of our initial public offering (or 18 months or 21 months, as applicable) or (B) with respect to any other provision relating to the rights of holders of shares of our Class A common stock; and (iii) waive
their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination within 15 months from the closing of our initial public offering (or 18 months or
21 months, as applicable) or any other approved extension of such period (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business
combination within the prescribed time frame); (c) the founder shares will automatically convert into shares of our Class A common stock at the time of our initial business combination as described herein; and (d) the founder shares are
entitled to registration rights. If we seek stockholder approval in connection with our initial business combination, our sponsor and each member of our management team have agreed to vote their founder shares and public shares in favor of our
initial business combination. 

 The founder shares are designated as Class B common stock and will automatically convert into shares of
our Class A common stock (which such shares of Class A common stock delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the trust account if we do not consummate an initial business
combination) at the time of our initial business combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an
as-converted basis, 20% of the sum of (i) the total number of all shares of common stock issued and outstanding upon completion of our initial public offering, plus (ii) the total number of shares of
Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business
combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial business
combination and any private placement warrants issued to our sponsor, its affiliates or any member of our management team upon conversion of working capital loans. 

Except as described herein, our sponsor and each member of our management team have agreed not to transfer, assign or sell any of their founder shares until
earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A common stock equals or exceeds $12.00 per share (as
adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial
business combination (provided that the 30-trading day must be completed prior to any such transfer, assignment or sale), or (y) the date on which we complete a liquidation, merger, capital stock exchange
or other similar transaction that results in all of our public stockholders having the right to exchange their shares of our Class A common stock for cash, securities or other property. We refer to such transfer restrictions as the lock-up. Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor and each member of our management team with respect to any founder shares. 

Preferred Stock 
 Our amended and restated certificate of
incorporation authorizes 1,000,000 shares of preferred stock and provides that shares of preferred stock may be issued from time to time in one or more series. Our board of directors will be authorized to fix the voting rights, if any, designations,
powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without stockholder
approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to
issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management. We have no preferred shares issued and outstanding at the date
hereof. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that we will not do so in the future. 

Warrants 
 Public Stockholders’ Warrants 

Each whole warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as
discussed below, at any time commencing on the later of one year from the closing of our initial public offering and 30 days after the completion of our initial business combination, except as discussed in the immediately succeeding paragraph.
Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of Class A common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional
warrants will be issued upon separation of the units, and accordingly, we will round down to the nearest whole number the number of warrants to be issued to holders. Only whole warrants will trade. If, upon separation of the units, a holder of
warrants would be entitled to receive a fractional warrant, we will round down to the nearest whole number the number of warrants to be issued to such holder. Accordingly, unless you purchase at least two units, you will not be able to receive or
trade a whole warrant. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. 

 We will not be obligated to deliver any Class A common stock pursuant to the exercise of a warrant and
will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current,
subject to our satisfying our obligations described below with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and we will not be obligated to issue a share of Class A common stock
upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the
warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire
worthless. In no event will we be required to net cash settle any warrant upon the exercise thereof. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have
paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit. 
 We have agreed that as soon as
practicable, but in no event later than twenty business days after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement for the registration, under the
Securities Act, of the Class A common stock issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of our initial business
combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement; provided
that if our Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities
Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required
to file or maintain in effect a registration statement, but we will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement
covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration
statement and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but we
will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that
number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value”
(defined below) less the exercise price of the warrants by (y) the fair market value. The “fair market value” as used in this paragraph shall mean the volume weighted average price of the Class A common stock for the 10 trading
days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent. 
 Redemption of warrants when the
price per share of Class A common stock equals or exceeds $18.00. 
 Once the warrants become exercisable, we may redeem the outstanding public
warrants: 
  

	 	•	 	 in whole and not in part; 

 

	 	•	 	 at a price of $0.01 per warrant; 

 

	 	•	 	 upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

  

	 	•	 	 if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as
adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below under the heading “—Anti-Dilution Adjustments”) on the trading day prior to the date on which we send the
notice of redemption to the warrant holders. 

 We will not redeem the public warrants as described above unless a registration statement under the
Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. If and when the public warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all
applicable state securities laws. 
 We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is
at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant
prior to the scheduled redemption date. Any such exercise would not be done on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. However, the price per share of
the Class A common stock may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below under the heading “Anti-dilution
Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. 
 Redemption procedures.

 A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to
exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount
as a holder may specify) of the shares of Class A common stock issued and outstanding immediately after giving effect to such exercise. 

Anti-dilution Adjustments. 
 If the number of outstanding
shares of Class A common stock is increased by a stock dividend payable in shares of Class A common stock, or by a split-up of common stock or other similar event, then, on the effective date of such
stock dividend, split-up or similar event, the number of shares of Class A stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of common
stock. A rights offering made to all or substantially all holders of common stock entitling holders to purchase Class A common stock at a price less than the “historical fair market value” (as defined below) will be deemed a stock
dividend of a number of shares of Class A common stock equal to the product of (i) the number of shares of Class A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights
offering that are convertible into or exercisable for Class A common stock) and (ii) one minus the quotient of (x) the price per share of Class A common stock paid in such rights offering and (y) the historical fair market
value. For these purposes, (i) if the rights offering is for securities convertible into or exercisable for shares of Class A common stock, in determining the price payable for Class A common stock, there will be taken into account
any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “historical fair market value” means the volume weighted average price of shares of Class A common stock as
reported during the 10 trading day period ending on the trading day prior to the first date on which the Class A common stock trades on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other
assets to all or substantially all of the holders shares of the Class A common stock on account of such Class A common stock (or other securities into which the warrants are convertible), other than (a) as described above,
(b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the Class A common stock during the 365-day period
ending on the date of declaration of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise
price or to the number of shares of Class A common stock issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy
the redemption rights of the holders of shares of Class A common stock in connection with a proposed initial business combination, (d) to satisfy the redemption rights of the holders of Class A common stock in connection with a
stockholder vote to amend our amended and restated certification of incorporation (A) to modify 

 
the substance or timing of our obligation to provide holders of shares of our Class A common stock the right to have their shares redeemed in connection with our initial business combination
or to redeem 100% of our public shares if we do not complete our initial business combination within 15 months from the closing of our initial public offering (or 18 months or 21 months, as applicable) or (B) with respect to any other provision
relating to the rights of holders of shares of our Class A common stock, or (e) in connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be
decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Class A common stock in respect of such event. 

If the number of outstanding shares of Class A common stock is decreased by a consolidation, combination, reverse stock split or reclassification of
Class A common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Class A common stock issuable on exercise of each
warrant will be decreased in proportion to such decrease in outstanding shares of Class A common stock. 
 Whenever the number of shares of
Class A common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction
(x) the numerator of which will be the number of shares of Class A common stock purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be the number of shares of
Class A common stock so purchasable immediately thereafter. 
 In addition, if (x) we issue additional shares of Class A common stock or
equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or
effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates, as
applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial
business combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of our Class A common stock during the 20 trading day period starting on the
trading day prior to the day on which we consummate our initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115%
of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above under “—Redemption of warrants when the price per share of Class A common stock equals or exceeds
$18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. 
 In case of any
reclassification or reorganization of the outstanding Class A common stock (other than those described above or that solely affects the par value of such Class A common stock), or in the case of any merger or consolidation of us with or
into another corporation in which any “person” or “group” (as such terms are used in Section 13(d) and 14(d) of the Exchange Act) acquires more than 50% of the voting power of our securities (and, in the case of a tender,
exchange or redemption offer, such offer results in a change of control of us), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety, the
holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the Class A common stock immediately theretofore purchasable and
receivable upon the exercise of the rights represented thereby, the kind and amount of shares of Class A common stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or
consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to
exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant will become exercisable will
be deemed to be the weighted average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election. If less than 70% of the consideration receivable by the holders of shares of
Class A common stock in such a transaction is payable in the form of Class A common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the

 
warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as
defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to
which the holders of the warrants otherwise do not receive the full potential value of the warrants. 
 The warrants will be issued in registered form under
a warrant agreement between American Stock Transfer & Trust Company, LLC, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of
(i) curing any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement, or defective provision, (ii) amending the provisions
relating to cash dividends on shares of common stock as contemplated by and in accordance with the warrant agreement or (iii) adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the
parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants, provided that the approval by the holders of at least 50% of the
then-outstanding public warrants is required to make any change that adversely affects the interests of the registered holders. You should review a copy of the warrant agreement is filed to our Annual Report on Form
10-K. 
 The warrant holders do not have the rights or privileges of holders of common stock and any voting rights
until they exercise their warrants and receive Class A common stock. After the issuance of Class A common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be
voted on by stockholders. 
 No fractional warrants will be issued upon separation of the units, and accordingly, we will round down to the nearest whole
number the number of warrants to be issued to holders. Only whole warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole
number the number of shares of Class A common stock to be issued to the warrant holder. 
 We have agreed that, subject to applicable law, any action,
proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we
irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any
claim for which the federal district courts of the United States of America are the sole and exclusive forum. 
 Private Placement Warrants 

Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units
in our initial public offering. The private placement warrants (including the shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the
completion of our initial business combination (except pursuant to limited exceptions to our officers and directors and other persons or entities affiliated with the initial purchasers of the private placement warrants) and they will not be
redeemable by us. Holders of the private placement warrants will have the option to exercise the private placement warrants on a cashless basis. Any amendment to the terms of the private placement warrants or any provision of the warrant agreement
with respect to the private placement warrants will require a vote of holders of at least 50% of the number of the then outstanding private placement warrants. 

If holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its
warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair
market value” (defined below) over the exercise price of the warrants by (y) the fair market value. For these purposes, the “fair market value” shall mean the average reported closing price of the Class A common stock for
the 10 trading days period ending on the trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. 

 In order to fund working capital deficiencies or finance transaction costs in connection with an intended
initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the
post business combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants. 

Dividends 
 We have not paid any cash dividends on our
common stock to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and
general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will be within the discretion of our board of directors at such time. Further,
if we incur any indebtedness in connection with a business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith. 

Our Transfer Agent and Warrant Agent 
 The transfer agent
for our common stock and warrant agent for our warrants is American Stock Transfer & Trust Company, LLC. We have agreed to indemnify American Stock Transfer & Trust Company, LLC in its roles as transfer agent and warrant agent, its
agents and each of its stockholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any claims and losses due to any gross negligence or
intentional misconduct of the indemnified person or entity. 
 Amended and Restated Certificate of Incorporation 

Our amended and restated certificate of incorporation contains certain requirements and restrictions relating to our initial public offering that will apply to
us until the completion of our initial business combination. These provisions cannot be amended without the approval of holders of 65% of our common stock. 

Our sponsor and its permitted transferees, if any, who will collectively beneficially own 20.0% of our common stock upon the closing of our initial public
offering (assuming they did not purchase any units in our initial public offering), will participate in any vote to amend our amended and restated certificate of incorporation and will have the discretion to vote in any manner they choose.
Specifically, our amended and restated certificate of incorporation provides, among other things, that: 
  

	 	•	 	 If we have not consummated an initial business combination within 15 months from the closing of our initial
public offering (or 18 months or 21 months, as applicable), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public
shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released
to us to pay our taxes that were paid by us or are payable by us, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding public shares, which redemption will completely extinguish public
stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders
and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law; 

	 	•	 	 Prior to or in connection with our initial business combination, we may not issue additional securities that
would entitle the holders thereof to (i) receive funds from the trust account or (i) vote as a class with our public shares (a) on our initial business combination or on any other proposal presented to stockholders prior to or in
connection with the completion of an initial business combination or (b) to approve an amendment to our amended and restated certificate of incorporation to (x) extend the time we have to consummate a business combination beyond 15 months
from the closing of our initial public offering (or 18 months or 21 months, as applicable) or (y) amend the foregoing provisions; 

  

	 	•	 	 Although we do not intend to enter into a business combination with a target business that is affiliated with our
sponsor, our directors or our officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from independent investment banking firm or another
independent entity that commonly renders valuation opinions that such a business combination is fair to our company from a financial point of view; 

  

	 	•	 	 If a stockholder vote on our initial business combination is not required by applicable law or stock exchange
listing requirements and we do not decide to hold a stockholder vote for business or other reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and
will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required
under Regulation 14A of the Exchange Act; 

  

	 	•	 	 So long as our securities are then listed on the NYSE, our initial business combination must occur with one or
more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the
trust account) at the time of the agreement to enter into the initial business combination; 

  

	 	•	 	 If our stockholders approve an amendment to our amended and restated certificate of incorporation (A) that
would modify the substance or timing of our obligation to provide holders of shares of our Class A common stock the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares
if we do not complete our initial business combination within 15 months from the closing of our initial public offering (or 18 months or 21 months, as applicable) or (B) with respect to any other provision relating to the rights of holders of
shares of our Class A common stock, we will provide our public stockholders with the opportunity to redeem all or a portion of their shares of shares of our Class A common stock upon such approval at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay
our taxes divided by the number of the then-outstanding public shares, subject to the limitations described herein; 

  

	 	•	 	 If we anticipate that we may not be able to consummate our initial business combination within 15 months, we may,
but are not obligated to, extend the period of time to consummate a business combination by two additional three-month periods (for a total of up to 21 months from the closing of our initial public offering to complete a business combination),
provided that (i) our sponsor or its affiliates or designees, upon five business days’ advance notice prior to each deadline, must, in each case, deposit into the trust account an additional $0.10 per share of Class A common stock on
or prior to the date of such deadline and (ii) at such additional deposits, in each case, our sponsor or its affiliates or designees will receive an additional 1,150,000 private placement warrants, with the same terms as the original private
placement warrants (our stockholders will not be entitled to vote on, or redeem their shares in connection with, any such extension; this feature is different from some other special purpose acquisition companies, in which any extension of the
company’s period to consummate an initial business combination would require a vote of the company’s stockholders and in connection with such vote stockholders would have the right to redeem their public shares); and 

 

	 	•	 	 We will not effectuate our initial business combination solely with another blank check company or a similar
company with nominal operations. 

 In addition, our amended and restated certificate of incorporation provides that under no
circumstances will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. 

 Certain Anti-takeover Provisions of Delaware Law and our Amended and Restated Certificate of
Incorporation and Bylaws 
 We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. This statute prevents
certain Delaware corporations, under certain circumstances, from engaging in a “business combination” with: 
  

	 	•	 	 a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested
stockholder”); 

  

	 	•	 	 an affiliate of an interested stockholder; or 

 

	 	•	 	 an associate of an interested stockholder, for three years following the date that the stockholder became an
interested stockholder. 

 A “business combination” includes a merger or sale of more than 10% of our assets. However, the above
provisions of Section 203 do not apply if: 
  

	 	•	 	 our board of directors approves the transaction that made the stockholder an “interested stockholder,”
prior to the date of the transaction; 

  

	 	•	 	 after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that
stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or 

 

	 	•	 	 on or subsequent to the date of the transaction, the initial business combination is approved by our board of
directors and authorized at a meeting of our stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.

 Our amended and restated certificate of incorporation provides that our board of directors will be classified into three classes of
directors. As a result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy contest at two or more annual meetings. 

Our authorized but unissued common stock and preferred stock will be available for future issuances without stockholder approval and could be utilized for a
variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could render more difficult or
discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise. 
 Exclusive Forum for Certain Lawsuits

 Our amended and restated certificate of incorporation require, unless we consent in writing to the selection of an alternative forum, that
(i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee to us or our stockholders, (iii) any action asserting a
claim against us, our directors, officers or employees arising pursuant to any provision of the DGCL or our amended and restated certificate of incorporation or bylaws, or (iv) any action asserting a claim against us, our directors, officers or
employees governed by the internal affairs doctrine may be brought only in the Court of Chancery in the State of Delaware, except any claim (A) as to which the Court of Chancery of the State of Delaware determines that there is an indispensable
party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive
jurisdiction of a court or forum other than the Court of Chancery or (C) for which the Court of Chancery does not have subject matter jurisdiction, as to which the Court of Chancery and the federal district court for the District of Delaware
shall have concurrent jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder’s counsel. Although we believe this provision benefits
us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect
of discouraging lawsuits against our directors and officers, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. 

Notwithstanding the foregoing, our amended and restated certificate of incorporation will provide that the exclusive forum provision will not apply to suits
brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to
enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Additionally, unless we consent in writing to the selection of an alternative 

 
forum, the federal courts shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act against us or any of our directors,
officers, other employees or agents. Section 22 of the Securities Act, however, created concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and
regulations thereunder. Accordingly, there is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies’ charter documents has been challenged in legal
proceedings. While the Delaware courts have determined that such exclusive forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions, and there
can be no assurance that such provisions will be enforced by a court in those other jurisdictions. Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of and consented to these
provisions; however, we note that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. 
 Special
Meeting of Stockholders 
 Our bylaws provide that special meetings of our stockholders may be called only by a majority vote of our board of directors,
by our Chief Executive Officer or by our Chairman. 
 Advance Notice Requirements for Stockholder Proposals and Director Nominations 

Our bylaws provide that stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors
at our annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice will need to be received by the company secretary at our principal executive offices not later than the close of
business on the 90th day nor earlier than the opening of business on the 120th day prior to the anniversary date of the immediately preceding annual meeting of stockholders. Pursuant to Rule 14a-8 of the
Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the notice periods contained therein. Our bylaws also specify certain requirements as to the form and content of a stockholders’ meeting. These provisions
may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders. 

Action by Written Consent 
 Subsequent to the consummation
of the initial public offering, any action required or permitted to be taken by our common stockholders must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent of the stockholders
other than with respect to our Class B common stock. 
 Classified Board of Directors 

Our board of directors is divided into three classes, Class I, Class II and Class III, with members of each class serving staggered three-year
terms. Our amended and restated certificate of incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors. Subject to the terms of any preferred stock, any or all of the directors may
be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of our capital stock entitled to vote generally in the election of directors, voting
together as a single class. Any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office. 

 Class B Common Stock Consent Right 

For so long as any shares of Class B common stock remain outstanding, we may not, without the prior vote or written consent of the holders of a majority
of the shares of Class B common stock then outstanding, voting separately as a single class, amend, alter or repeal any provision of our certificate of incorporation, whether by merger, consolidation or otherwise, if such amendment, alteration
or repeal would alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B common stock. Any action required or permitted to be taken at any meeting of the holders of shares of
Class B common stock may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of the outstanding Class B common stock
having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares of Class B common stock were present and voted. 

Registration and Stockholder Rights 
 The holders of the
founder shares, private placement warrants and any warrants that may be issued upon conversion of working capital loans, if any (and any shares of Class A common stock issuable upon the exercise of the private placement warrants and warrants
that may be issued upon conversion of working capital loans) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of our initial public offering. The holders of these
securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed
subsequent to our completion of our initial business combination. However, the registration rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the
applicable lockup period, which occurs (i) in the case of the founder shares, as described in the following paragraph, and (ii) in the case of the private placement warrants and the respective shares of Class A common stock underlying
such warrants, 30 days after the completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements. 

Except as described herein, our sponsor and each member of our management team have agreed not to transfer, assign or sell their founder shares until the
earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A common stock equals or exceeds $12.00 per share (as
adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business
combination (provided that the 30-trading day must be completed prior to any such transfer, assignment or sale), or (y) the date on which we complete a liquidation, merger, capital stock exchange or other
similar transaction that results in all of our public stockholders having the right to exchange their common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of our
sponsor with respect to any founder shares. 
 Listing of Securities 

Our units, Class A common stock, and warrants are listed on the NYSE under the symbols “MNTN.U,” “MNTN” and “MNTN WS,”
respectively.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]